InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EK (LPS from E. coli K12) | Translational genetics identifies a phosphorylation switch in CARD9 required ... | 2024 | Cell Rep. | Brandt M. et al. | DOI: 10.1016/j.celrep.2024.113944 |
| Primocin® | OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma. | 2024 | JCI Insight | Nguyen T.T. et al. | DOI: 10.1172/jci.insight.172565 |
| Puromycin | METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 fac... | 2024 | Sci Rep. | Wu X. et al. | DOI: 10.1038/s41598-024-55932-7 |
| G418 (Geneticin) | METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 fac... | 2024 | Sci Rep. | Wu X. et al. | DOI: 10.1038/s41598-024-55932-7 |
| pFUSE-hIgG1-Fc | BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. | 2024 | J Immunother Cancer | Kim Y.S. et al. | DOI: 10.1136/jitc-2023-008303 |
| Puromycin | BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. | 2024 | J Immunother Cancer | Kim Y.S. et al. | DOI: 10.1136/jitc-2023-008303 |
| Blasticidin | dCas13-mediated translational repression for accurate gene silencing in mamma... | 2024 | Nat Commun. | Apostolopoulos A. et al. | DOI: 10.1038/s41467-024-46412-7 |
| Hygromycin B Gold | dCas13-mediated translational repression for accurate gene silencing in mamma... | 2024 | Nat Commun. | Apostolopoulos A. et al. | DOI: 10.1038/s41467-024-46412-7 |
| AddaVax™ | Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum pr... | 2024 | Int J Biol Macromol. | Wang W. et al. | DOI: 10.1016/j.ijbiomac.2024.130820 |
| STING-H232 | Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Hu... | 2024 | Cancer Res Commun | Boda A.R. et al. | DOI: 10.1158/2767-9764.CRC-24-0095 |
| STING-HAQ | Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Hu... | 2024 | Cancer Res Commun | Boda A.R. et al. | DOI: 10.1158/2767-9764.CRC-24-0095 |
| STING | Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Hu... | 2024 | Cancer Res Commun | Boda A.R. et al. | DOI: 10.1158/2767-9764.CRC-24-0095 |
| HEK-Blue™ ISG-KO-STING Cells | Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Hu... | 2024 | Cancer Res Commun | Boda A.R. et al. | DOI: 10.1158/2767-9764.CRC-24-0095 |
| R848 (Resiquimod) | Alendronate modulates cytokine responses in healthy young individuals after B... | 2024 | Immunol Lett. | Bulut O. et al. | DOI: 10.1016/j.imlet.2024.106851 |
| Poly(I:C) HMW | Alendronate modulates cytokine responses in healthy young individuals after B... | 2024 | Immunol Lett. | Bulut O. et al. | DOI: 10.1016/j.imlet.2024.106851 |
| Zeocin® | Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase... | 2024 | Life Sci Alliance | Damianou A. et al. | DOI: 10.26508/lsa.202302245 |
| Blasticidin | Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase... | 2024 | Life Sci Alliance | Damianou A. et al. | DOI: 10.26508/lsa.202302245 |
| Hygromycin B Gold | Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase... | 2024 | Life Sci Alliance | Damianou A. et al. | DOI: 10.26508/lsa.202302245 |
| Curdlan | Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated mac... | 2024 | Respir Res. | Cai R. et al. | DOI: 10.1186/s12931-024-02743-z |
| Human ACE2 & TMPRSS2a Expression Vector | Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechani... | 2024 | Physiol Res. | Zorad S. et al. | 73(1):27-35. |